Are you on the search for the most sustainable business model for your DTx within the EU? Keep reading!
In the last few years, we have seen an important growth in investments for DTx in the European market; but what are the business models that will make a DTx company successful in Europe? Finding the right commercialisation model to scale can be challenging, but your HealthXL community is here to help. This meeting will look at the best routes to market for DTx in the EU. If this sounds like your day-to-day work, get involved!
The most scalable and sustainable business models for DTx companies in the EU market; what are the routes for successful growth?
Insights in how to scale DTx in Europe: examples of partnerships and commercial models followed by leading companies
What is the best route to market for your product? Factors that determine the best commercialization models in Europe (e.g country, disease, type of product, etc)